Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-18.46M
↑ 31% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-26.92M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-18.46M | +42.6% |
| 2025 | $-32.17M | +66.7% |
| 2024 | $-96.71M | +13.8% |
| 2023 | $-112.21M | -29.1% |
| 2022 | $-86.91M | -22.8% |
| 2021 | $-70.75M | -1353.7% |
| 2020 | $5.64M | -91.5% |
| 2019 | $66.00M | +151.5% |
| 2018 | $26.24M | -47.7% |
| 2017 | $50.15M | - |